• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Layoffs loom for up to 2,000 Medtronic workers

Layoffs loom for up to 2,000 Medtronic workers

February 22, 2011 By MassDevice staff

MDT

Medtronic Inc. (NYSE:MDT) plans to lay off up to 5 percent of its workers in a bid to shore up its long-term prospects, despite reporting strong third-quarter sales and earnings numbers.

The news means job losses for between 1,500 and 2,000 workers worldwide. The company said the move is meant to “align its cost structure to current market conditions and continue to position Medtronic for long-term sustainable growth.”

“We are delivering on our pipeline to drive share in our core markets and strong growth in emerging technologies,” chairman and CEO Bill Hawkins said in prepared remarks. “At the same time, we are restructuring our business and leveraging our global infrastructure to be more in-line with market conditions, which positions us well to deliver market-leading performance.”

Medtronic posted profits of $924 million, or 86 cents per diluted share, on sales of $3.96 billion for the three months ended Jan. 28. That’s a 2.9 percent top-line increase and an 11.2 percent boost to the bottom line when compared with earnings of $831 million, or 75 cents per diluted share, on sales of $3.85 billion during the same period last year.

International sales accounted for 43 percent of total revenues at $1.70 billion, with “emerging market revenue” of $350 million, up 26 percent.

Medtronic’s bread-and-butter cardiac and vascular group reported sales of $2.10 billion, up 2 percent. But its cardiac rhythm disease management arm saw sales slip by the same percentage to $1.22 billion, as implantable cardiac defibrillator sales were down 2 percent to $735 million. Pacemaker sales also slipped 2 percent to $450 million.

The Fridley, Minn.-based medical device monolith said its Physio-Control external defibrillator division delivered a sales increase of 4 percent, to $104 million, but added that the company plans to start shopping the unit again to potential buyers.

Medtronic lowered the top end of its fiscal 2011 diluted earnings per share estimate to $3.40 but held steady with its low-end forecast of $3.38 diluted EPS, saying it’s “comfortable” with analysts’ consensus estimate of $3.40. Its prior forecast predicted earnings of between $3.40 and $3.42. Full year sales are still expected to grow between 2 percent and 4 percent.

MDT shares were down 2.5 percent to $40.26 in mid-morning trading.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: Q4

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy